However, early treatment with MTX is associated with a mean delay in the development of cataract requiring surgery of 3.
5 years.
However, additional topical steroids or systemic immunosuppressive drugs are often required.
About three-quarters of all children with JIA in the CARRA Registry received nonbiologic DMARD.
However, controlled studies in uveitis are still missing, so that treatment with MTX and all other immunosuppressive drugs (ciclosporine A, azathioprine, mycophenolate mofetil) only reaches an evidence level III (expert opinion, clinical experience or descriptive study).
Eighteen patients (18/22; 82%) showed improvement of their uveitis with a significant decrease in activity of AC inflammation after a minimal period of 3 months of MTX treatment.
